
Molecular classification of MEDULLOBLASTOMA and its clinical implications
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Molecular classification of medulloblastoma is now firmly in place. In this episode the 4 key subtypes that is
- WNT ACTIVATED
- SHH ACTIVATED (p53 mutant and wild type)
- GROUP 3
- GROUP 4
are discussed with an emphasis on how these differ from each other. Also you will get to know what additional information this molecular classification will give to clinicians. If you are more of an instagrammer you may like to visit the instagram page where this topic has been presented in text format.
Here is the link to instagram profile: https://www.instagram.com/oncopodindia/
please share your feedback on oncopodindia@gmail.com
What listeners say about Molecular classification of MEDULLOBLASTOMA and its clinical implications
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.